SI
INSM icon

Saxon Interests’s Insmed INSM Stock Holding History

Saxon Interests’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,163
Closed -$425K – 196
2024
Q4 		$425K Sell
6,163
-454
-7% -$32.7K 0.19% 112
2024
Q3 		$483K Buy
6,617
+32
+0.5% +$2.36K 0.22% 98
2024
Q2 		$441K Buy
+6,585
New +$255K 0.21% 107

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Saxon Interests's INSM Position: Q1 2025 in Review

Saxon Interests sold out of Insmed (INSM) in Q1 2025, closing a stake of 6,163 shares — an estimated $425K sold.

Saxon Interests first reported a position in INSM in Q2 2024 and held it in 3 quarters. The position peaked at $483K in Q3 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

  • Saxon Interests reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
  • Saxon Interests sold 6,163 Insmed shares in Q1 2025, an estimated $425K.
  • Saxon Interests first reported a position in Insmed in Q2 2024 and held it in 3 quarters.
  • Saxon Interests's Insmed position peaked at $483K in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on Saxon Interests's 13F filing for Q1 2025, filed 25 Apr 2025.